Literature DB >> 24696610

Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells.

Jun Wei1, Zhong-Xin Zhao1, Yang Li1, Zhu-Qing Zhou1, Tian-Geng You1.   

Abstract

AIM: To study the effects of cortactin on the tumor biology of SGC-7901 cells and identify the mechanism involved in the process.
METHODS: Cell lines in which cortactin was stably overexpressed or knocked down as well as the respective control cell lines were established by standard molecular methods. The effects of cortactin on the proliferation, migration and invasion capacity of SGC-7901 cells were assessed by the MTT assay, colony formation, flow cytometry, transwell migration and matrigel invasion. Nude mouse models were also used to assess the role of cortactin in the growth and metastasis of SGC-7901 cells in vivo. Western blotting analysis was performed to detect the expression of epidermal growth factor receptor (EGFR) and downstream molecules.
RESULTS: Cell lines in which cortactin was stably overexpressed or knocked down as well as control cell lines were successfully established and designated as LV5-cortactin-SGC, LV5-SGC, LV3-shRNA-SGC and LV3-SGC. Cortactin overexpression promoted SGC-7901 cell migration (340.7 ±12.6 vs 229.1 ± 23.2, P < 0.01) and invasion (71.6 ± 5.2 vs 48.4 ± 3.6, P < 0.01). Cortactin downregulation impaired SGC-7901 cell migration (136.2 ± 19.8 vs 225 ± 17) and invasion (29.2 ± 5.2 vs 49.6 ± 3.8, P < 0.01). The results from the MTT and colony formation assays results indicated increased LV5-cortactin-SGC cell proliferation and decreased LV3-shRNA-SGC cell proliferation compared to the control cells. Flow cytometry analysis demonstrated that cortactin overexpression promoted the proliferation index of SGC-7901 cells, and the results were reversed when cortactin was downregulated. Mouse tumor models confirmed that cortactin expression increased SGC-7901 cell proliferation and metastasis in vivo. Western blotting analysis revealed that cortactin elevated EGFR expression and activated the downstream molecules.
CONCLUSION: Cortactin expression promoted the migration, invasion and proliferation of SGC-7901 cells both in vivo and in vitro. The EGFR signaling pathway is mechanistically involved.

Entities:  

Keywords:  Cortactin; Epidermal growth factor receptor; Gastric cancer; Invasion; Metastasis; Proliferation

Mesh:

Substances:

Year:  2014        PMID: 24696610      PMCID: PMC3964399          DOI: 10.3748/wjg.v20.i12.3287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.

Authors:  Paul Timpson; Danielle K Lynch; Daniel Schramek; Francesca Walker; Roger J Daly
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

2.  VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer.

Authors:  Xin Wang; Weiguo Cao; Mingcong Mo; Wei Wang; Huita Wu; Jiejun Wang
Journal:  J Surg Oncol       Date:  2010-09-15       Impact factor: 3.454

3.  Alternate dosing of cetuximab for patients with metastatic colorectal cancer.

Authors:  Joleen M Hubbard; Steven R Alberts
Journal:  Gastrointest Cancer Res       Date:  2013-03

4.  Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

Authors:  Till Sebastian Clauditz; Artur Gontarewicz; Patrick Lebok; Maria-Christina Tsourlakis; Tobias J Grob; Adrian Münscher; Guido Sauter; Carsten Bokemeyer; Rainald Knecht; Waldemar Wilczak
Journal:  Oral Oncol       Date:  2012-06-12       Impact factor: 5.337

5.  Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.

Authors:  Sang Jae Noh; Hyun Ah Baek; Ho Sung Park; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Min Ho Kim; Ju Hyung Lee; Myoung Ja Chung
Journal:  Pathol Res Pract       Date:  2013-04-15       Impact factor: 3.250

6.  Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.

Authors:  A S Patel; G L Schechter; W J Wasilenko; K D Somers
Journal:  Oncogene       Date:  1998-06-25       Impact factor: 9.867

7.  Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters.

Authors:  Wen-Chiuan Tsai; Jong-Shiaw Jin; Wei-Kuo Chang; De-Chuan Chan; Ming-Kung Yeh; Shiou-Chih Cherng; Li-Fan Lin; Lai-Fa Sheu; You-Chen Chao
Journal:  J Histochem Cytochem       Date:  2007-05-17       Impact factor: 2.479

Review 8.  Novel targeted agents for gastric cancer.

Authors:  Lian Liu; Ning Wu; Jin Li
Journal:  J Hematol Oncol       Date:  2012-06-18       Impact factor: 17.388

9.  Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility.

Authors:  Wenqi Wang; Yang Liu; Kan Liao
Journal:  BMC Cell Biol       Date:  2011-11-13       Impact factor: 4.241

10.  Expression of cortactin and focal adhesion kinase in colorectal adenocarcinoma: correlation with clinicopathologic parameters and their prognostic implication.

Authors:  Yo Na Kim; Ji Eun Choi; Jun Sang Bae; Kyu Yun Jang; Myoung Ja Chung; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Ho Sung Park
Journal:  Korean J Pathol       Date:  2012-10-25
View more
  10 in total

1.  Knockdown of EGFR inhibits growth and invasion of gastric cancer cells.

Authors:  Y Zhen; L Guanghui; Z Xiefu
Journal:  Cancer Gene Ther       Date:  2014-11-14       Impact factor: 5.987

2.  Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.

Authors:  W Ruoming; Y Zhen; Z Tengteng; H Jisheng
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

3.  Cortactin Mediates Apoptosis of Gastric Epithelial Cells Induced by VacA Protein of Helicobacter pylori.

Authors:  Hui Chang; Dongfeng Chen; Bosheng Ni; Qianfei Zuo; Chunhua Wang; Ran Han; Chunhui Lan
Journal:  Dig Dis Sci       Date:  2015-08-20       Impact factor: 3.199

4.  Evaluation of Cortactin and HS1 Genes Expression: New Players in Adult B-Cell Acute Lymphoblastic leukemia.

Authors:  Salah Aref; Mohamed Al Agdar; Ahmed Ramez; Tarek Abou Zeid; Mohamed Sabry; Nada Khaled
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

5.  MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.

Authors:  Zhuo Chen; Shengnan Liu; Yuan Xia; Kejian Wu
Journal:  Med Sci Monit       Date:  2016-12-01

6.  Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene.

Authors:  Li Li; Lixia Zhu; Yungui Wang; Jingjing Zhu; Wanzhuo Xie; Xiujin Ye
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

7.  Cortactin Is Required for Efficient FAK, Src and Abl Tyrosine Kinase Activation and Phosphorylation of Helicobacter pylori CagA.

Authors:  Jakob Knorr; Irshad Sharafutdinov; Florian Fiedler; Delara Soltan Esmaeili; Manfred Rohde; Klemens Rottner; Steffen Backert; Nicole Tegtmeyer
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

Review 8.  Regulators of Actin Dynamics in Gastrointestinal Tract Tumors.

Authors:  Konrad Steinestel; Eva Wardelmann; Wolfgang Hartmann; Inga Grünewald
Journal:  Gastroenterol Res Pract       Date:  2015-08-04       Impact factor: 2.260

9.  Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell line.

Authors:  Zheng Jiang; Yao Liu; Chuan Wang
Journal:  Onco Targets Ther       Date:  2016-08-09       Impact factor: 4.147

10.  Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1.

Authors:  Jagadeesh Janjanam; Gadiparthi N Rao
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.